This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Kimi Nishikawa: Innovator in Complement Protein Research
Introduction
Kimi Nishikawa is a notable inventor based in Greenwich, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid aptamers. Her work focuses on the complement protein C3 and its biologically active proteolytic products.
Latest Patents
Kimi holds a patent titled "Aptamer modulators of complement protein C3 and biologically active proteolytic products thereof." This invention relates to nucleic acid aptamers that recognize and bind the complement protein C3 or its biologically active proteolytic products. The patent describes bi-functional aptamer constructs that specifically bind with C3b or iC3b, as well as another target protein. The use of these molecular constructs for commandeering the opsonization process is also detailed in her patent.
Career Highlights
Kimi Nishikawa is affiliated with the State University of New York, where she continues her research and innovation in the field of biotechnology. Her work has garnered attention for its potential applications in medical and therapeutic settings.
Collaborations
Kimi collaborates with esteemed colleagues, including Hua Shi and Albert J T Millis, who contribute to her research endeavors.
Conclusion
Kimi Nishikawa's innovative work in the field of complement protein research exemplifies the impact of biotechnology on modern science. Her contributions through her patent and collaborations highlight her role as a leading inventor in this important area of study.